Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies. [electronic resource]
Producer: 20080818Description: 3044-51 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antigens, CD -- metabolism
- Antineoplastic Agents -- administration & dosage
- Apoptosis Regulatory Proteins -- metabolism
- Area Under Curve
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Hematologic Neoplasms -- drug therapy
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Programmed Cell Death 1 Receptor
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.